Skip to main content
Caplight Logo









Ossiform

Ossiform

Private
OdenseHealthcare & Life Scienceshttps://ossiform.com

Last Round

Convertible Debt

May 30, 2025

Total Funding Raised

$13.38M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ossiform operates in Healthcare & Life Sciences and is based in Odense. Its latest recorded funding round was a Convertible Debt round in May 2025.

Ossiform is a medical technology company that develops and manufactures 3D printed, patient-specific, and resorbable bone implants made from tricalcium phosphate.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ossiform Comparables

Compare Ossiform with similar companies based on industry and business-model similarity.

Ossiform comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cerhum
87%
Mimetis Biomaterials
81%
Osteopore Ltd
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ossiform Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtMay 30, 2025
Series BOct 5, 2022
Series AMay 18, 2020
SeedJun 1, 2018
GrantJan 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Thea Wulff Olesen

Group CEO

Executive Team

Martin Bonde Jensen

CTO

Executive Team

For institutional investors. Book with your work email.

Ossiform Investors

Notable investors and investment history

Ossiform investors
InvestorRounds
Innovation Fund DenmarkGrant
West Hill CapitalConvertible Debt, Series B, Series A
PSV TechSeed
Asimov VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors grew 147% MoM, reaching 5.9K.

  • Jul 26, 2026

    Monthly visitors grew 37% MoM, reaching 2.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • expands_offices_inOct 19, 2026

    Ossiform continues to expand its presence in the United States as its representatives meet investors, clinicians, and strategic partners.

  • attends_eventOct 19, 2026

    Ossiform is set to attend the 2026 Musculoskeletal New Ventures Conference in Tennessee on Oct 27th-28th '26, where its CEO, Thea Wulff Olesen, is invited to present the company and its vision for orthopedic repair.

  • attends_eventOct 19, 2026

    Ossiform CEO Thea Wulff Olesen and U.S. Commercial Lead Mark Singer are scheduled to attend MNVC 2026 in Tennessee on Oct 27-28 '26, with Olesen invited to present the company and its vision for orthopedic repair.

  • attends_eventSep 24, 2026

    Ossiform is attending the annual European Foot & Ankle Society (EFAS) Congress in Germany from Oct 1st–3rd '26, where its chief medical and commercial officers look forward to engaging with physicians, researchers, and industry professionals.

Book a demo to see all news

For institutional investors. Book with your work email.

Ossiform Filings

Explore SEC and related filing metadata, where available.

Ossiform filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ossiform's valuation, stock price, and market status.

Is Ossiform a public or private company?

Ossiform is a private company.

What is the current stock price of Ossiform?

Ossiform is a private company, so its shares have no public market price. Caplight tracks Ossiform's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ossiform worth (valuation)?

Valuation information for Ossiform is not publicly available.

Can I buy Ossiform stock?

Ossiform shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ossiform's last funding round?

Ossiform's most recent funding round was Convertible Debt on May 30, 2025.

Who are the main investors in Ossiform?

Key investors in Ossiform include West Hill Capital, PSV Tech.

Will Ossiform IPO soon?

No public IPO plans have been announced for Ossiform.

How can I track Ossiform secondary market activity?

Caplight tracks bids, offers, and trades in Ossiform's shares on secondary markets.

Firmographic Details

HeadquartersOdense
Employee Range14
Year Founded2017
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?